Fortress Biotech IncFortress Biotech Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The ESG score covers seventeen UN SDGs including: 'Good Health & Wellbeing', 'Reduced Inequalities' and 'Partnerships for the Goals'. This assessment of Fortress Biotech Inc is prepared by All Street Sevva using cutting edge NLP. The Sustainability score for Fortress Biotech Inc represents the company's reporting of the United Nations SDGs.

Fortress Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.1; made up of an environmental score of 6.0, social score of 3.2 and governance score of 3.2.

SDG Transparency Score for Fortress Biotech Inc 
Low
0 - 3

4.1

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Fortress Biotech Inc 
6.0

Environmental

3.2

Social

3.2

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
969Vertex Pharmaceuticals Inc
4.2
High
969Zentalis Pharmaceuticals Inc
4.2
High
989Fortress Biotech Inc
4.1
High
989Advanz Pharma Corp Ltd
4.1
High
989Abeona Therapeutics Inc
4.1
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Fortress Biotech Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Fortress Biotech Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Fortress Biotech Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Fortress Biotech Inc offer flexible work?

LockedSign up for free to unlock

Does Fortress Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Fortress Biotech Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Fortress Biotech Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose water use targets?

LockedSign up for free to unlock

Does Fortress Biotech Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Fortress Biotech Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Fortress Biotech Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Fortress Biotech Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Fortress Biotech Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Fortress Biotech Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Fortress Biotech Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose its waste policy?

LockedSign up for free to unlock

Does Fortress Biotech Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose energy use targets?

LockedSign up for free to unlock

Does Fortress Biotech Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Fortress Biotech Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Fortress Biotech Inc
These potential risks are based on the size, segment and geographies of the company.

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the treatment of X-linked severe combined immunodeficiency; Cosibelimab for metastatic cancers; CK-101 for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and CEVA101 for the treatment of severe traumatic brain injury in adults and children. The company's early stage product candidates include MB-102 for blastic plasmacytoid dendritic cell neoplasm; MB-101 for glioblastoma; MB-104 for multiple myeloma and light chain amyloidosis; MB-106 for B-cell non-hodgkin lymphoma; MB-103 for GBM & metastatic breast cancer to brain; MB-108; MB-105 for prostate and pancreatic cancers; and BAER-101. Its preclinical product candidates comprise AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; ConVax; and ONCOlogues, and oligonucleotide platform. It has collaboration arrangements with universities, research institutes, and pharmaceutical companies. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York.

Sorry!

Failed to process!